Increased risk for vascular complications due to GP IIb/IIIa-antagonists in patients with cardiogenic shock supported by intraaortic balloon pump (IABP)
Clinical Trials and Regulatory Science in Cardiology · 2015
DOI: 10.1016/j.ctrsc.2015.08.008 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Trials and Regulatory Science in Cardiology, 2015. Verfasst von Jens Röther und 5 weiteren Autor:innen. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Röther, J., Tröbs, M., Schuhbäck, A., Ludwig, J., Achenbach, S., & Schlundt, C. (2015). Increased risk for vascular complications due to GP IIb/IIIa-antagonists in patients with cardiogenic shock supported by intraaortic balloon pump (IABP). Clinical Trials and Regulatory Science in Cardiology. https://doi.org/10.1016/j.ctrsc.2015.08.008
Vancouver
Röther J, Tröbs M, Schuhbäck A, Ludwig J, Achenbach S, Schlundt C. Increased risk for vascular complications due to GP IIb/IIIa-antagonists in patients with cardiogenic shock supported by intraaortic balloon pump (IABP). Clinical Trials and Regulatory Science in Cardiology. 2015. doi:10.1016/j.ctrsc.2015.08.008
BibTeX
@article{Rther2015,
author = {Röther, Jens and Tröbs, Monique and Schuhbäck, Annika and Ludwig, Josef and Achenbach, Stephan and Schlundt, Christian},
title = {Increased risk for vascular complications due to GP IIb/IIIa-antagonists in patients with cardiogenic shock supported by intraaortic balloon pump (IABP)},
journal = {Clinical Trials and Regulatory Science in Cardiology},
year = {2015},
doi = {10.1016/j.ctrsc.2015.08.008}
}
EUVIMED